April 01, 2005
Intravenous Form of Nexium Approved
AstraZeneca today announced that a new administration formulation for its prescription proton pump inhibitor NEXIUM® (esomeprazole magnesium) has been approved by the US Food and Drug Administration (FDA). NEXIUM I.V. is now approved as an intravenous infusion or injection for the short-term treatment (up to 10 days) of gastroesophageal reflux disease (GERD) patients, with a history of erosive esophagitis, who are unable to take capsules.
Posted by news editor | Filed under: Acid Reflux Disease